Literature DB >> 11251274

Bronchial artery perfusion during cardiopulmonary bypass does not prevent ischemia of the lung in piglets: assessment of bronchial artery blood flow with fluorescent microspheres.

C Schlensak1, T Doenst, S Preusser, M Wunderlich, M Kleinschmidt, F Beyersdorf.   

Abstract

OBJECTIVE: Blood supply of the lungs during total cardiopulmonary bypass (CPB) is limited to flow through the bronchial arteries. This study was undertaken to assess the bronchial artery blood flow during CPB with fluorescent microspheres in a piglet model.
METHODS: We subjected ten piglets (mean weight 5.0+/-0.5 kg) to 120 min of normothermic, total CPB without aortic cross-clamping, followed by 60 min of post-bypass perfusion. Fluorescent microspheres were injected into the left atrium or the aortic cannula or distal to the cannula to assess bronchial artery blood flow before, during and after CPB. The reference samples were taken from the descending aorta. We compared the different sites of injection. Tissue samples of the lungs were taken before and 60 min after CPB.
RESULTS: Before CPB, total bronchial artery perfusion was 43.6+/-14.1 ml/min (4.8+/-1.3% of cardiac output) as by injection distal to the aortic cannula. These values were not different when microspheres were injected into the left atrium or the aortic cannula. There was no difference in scatter or in the amount of microspheres in the reference samples among the three injections sites. During CPB, bronchial artery perfusion was significantly decreased (4.4+/-2.4 ml/min vs. 40.0+/-5.0 ml/min before CPB) and returned to baseline values 60 min after CPB. Light microscopy of the tissue samples revealed alveolar septal thickening and a decrease in alveolar surface area after 60 min of reperfusion which was associated with a decreased capacity to oxygenate blood.
CONCLUSIONS: (1) Bronchial artery blood flow can quantitatively be assessed during CPB when microspheres are injected into the ascending aorta and the reference samples are taken from the descending aorta. (2) Despite adequate perfusion pressure bronchial artery blood flow is decreased substantially during CPB. (3) The decrease in blood flow and the ultrastructural changes present at the end of CPB suggest the presence of low-flow ischemia of the lung during total CPB.

Entities:  

Mesh:

Year:  2001        PMID: 11251274     DOI: 10.1016/s1010-7940(01)00581-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Changes in infant porcine pulmonary tissue oxylipins induced by cardiopulmonary bypass.

Authors:  Kelsey G Iguidbashian; Justin Robison; Ludmila Khailova; James Jaggers; Richard Ing; Scott Lawson; Suzanne M Osorio Lujan; Jelena Klawitter; Jesse A Davidson
Journal:  Pediatr Res       Date:  2022-06-09       Impact factor: 3.953

Review 2.  Prevention of lung injury in cardiac surgery: a review.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2014-06

3.  Elevated pulmonary dead space and coagulation abnormalities suggest lung microvascular thrombosis in patients undergoing cardiac surgery.

Authors:  Barry Dixon; Duncan J Campbell; John D Santamaria
Journal:  Intensive Care Med       Date:  2008-02-27       Impact factor: 17.440

4.  Deep hypothermic circulatory arrest with lung perfusion/ventilation in a patient with acute type a aortic dissection.

Authors:  Yiliam F Rodriguez-Blanco; Lester Garcia; Tania Brice; Marco Ricci; Tomas A Salerno
Journal:  Case Rep Med       Date:  2012-03-07

5.  A perioperative surgeon-controlled open-lung approach versus conventional protective ventilation with low positive end-expiratory pressure in cardiac surgery with cardiopulmonary bypass (PROVECS): study protocol for a randomized controlled trial.

Authors:  David Lagier; François Fischer; William Fornier; Jean-Luc Fellahi; Pascal Colson; Bernard Cholley; Samir Jaber; Karine Baumstarck; Catherine Guidon
Journal:  Trials       Date:  2018-11-13       Impact factor: 2.279

6.  Chronic respiratory disease and survival outcomes after extracorporeal membrane oxygenation.

Authors:  Tak Kyu Oh; Hyoung-Won Cho; Hun-Taek Lee; In-Ae Song
Journal:  Respir Res       Date:  2021-07-05

7.  Impact of Cardiopulmonary Bypass on Respiratory Mucociliary Function in an Experimental Porcine Model.

Authors:  Rodrigo Sánchez-Véliz; Maria José Carmona; Denise Aya Otsuki; Claudia Freitas; Anderson Benício; Elnara Marcia Negri; Luiz Marcelo Malbouisson
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

8.  Pulmonary artery perfusion versus no pulmonary perfusion during cardiopulmonary bypass in patients with COPD: a randomised clinical trial.

Authors:  Katrine B Buggeskov; Martin M Sundskard; Thomas Jonassen; Lars W Andersen; Niels H Secher; Hanne B Ravn; Daniel A Steinbrüchel; Janus C Jakobsen; Jørn Wetterslev
Journal:  BMJ Open Respir Res       Date:  2016-09-06

Review 9.  Pulmonary complications associated with veno-arterial extra-corporeal membrane oxygenation: a comprehensive review.

Authors:  Aurélien Roumy; Lucas Liaudet; Marco Rusca; Carlo Marcucci; Matthias Kirsch
Journal:  Crit Care       Date:  2020-05-11       Impact factor: 9.097

Review 10.  Pulmonary Complications of Cardiac Surgery.

Authors:  Tristan George Tanner; Mai O Colvin
Journal:  Lung       Date:  2020-11-11       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.